-
the entire field-of-view. We have a strong tradition of supporting PhD students in taking the lead of their own projects and developing them in the direction of their specific interests. As such, our PhDs
-
. We wish to lead collaborative interdisciplinary research from single-cell genomics to whole-body systems, transforming the basic understanding of cardiometabolic health, and accelerating its
-
on integration of experimentally based approaches with fundamental understanding of physical, chemical, and engineering principles, including simulation of the system’s behavior. The current research within the 3P
-
from atomic-level structural characterization to in vivo studies and clinical trials. We offer a dynamic and collaborative environment where students, postdocs, technicians, and scientists from various
-
(including Condensed Matter, Atomic, Molecular and Optical Physics). The application will be a two-step procedure as specified below. We seek to appoint an outstanding researcher based on scientific excellence
-
groups focused on topics spanning from basic to translational science. MolPharm encompasses multiple research groups with expertise ranging from atomic-level structural characterization to in vivo studies
-
examples illustrating your drive and abilities relevant to the position. The application deadline is 7th of March 2024. Interviews will take place mid-March 2024 UCPH is in the process of designing a new
-
The clinical professor acts as chair of the speciality and takes the lead in the general development of the speciality’s academic identity. Also, the clinical professor is the guarantor of the academic